MBAI — Medbright AI Investments Income Statement
0.000.00%
- CA$9.90m
- CA$8.96m
- 37
- 38
- 17
- 20
Annual income statement for Medbright AI Investments, fiscal year end - February 28th, CAD millions except per share, conversion factor applied.
2019 February 28th | 2020 February 29th | 2021 February 28th | 2022 February 28th | 2023 February 28th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.145 | 0.744 | 0.641 | 1.47 | 0.386 |
Operating Profit | -0.145 | -0.744 | -0.641 | -1.47 | -0.386 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.24 | -2.73 | -0.719 | -1.21 | -0.43 |
Net Income After Taxes | -1.24 | -2.73 | -0.719 | -1.21 | -0.43 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.24 | -2.73 | -0.719 | -1.21 | -0.43 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.24 | -2.73 | -0.719 | -1.21 | -0.43 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.169 | -0.21 | -0.042 | -0.059 | -0.02 |